Patient recruitment

Medable Partners With Datavant to Simplify Integration of Data Sources for Decentralized Clinical Trials

Monday, June 29, 2020 - 1:08pm

Medable Inc. , the leading software provider for decentralized clinical trials, and Datavant , the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.

Key Points: 
  • Medable Inc. , the leading software provider for decentralized clinical trials, and Datavant , the leader in helping healthcare organizations safely connect their data, today announced a partnership that will help clinical trial teams easily integrate multiple data sources to accelerate decentralized trial design, recruitment and data management.
  • Medable will integrate Datavants technology into Medables decentralized trials platform, allowing trial teams to combine real-world health records, claims, diagnostic and other data sources with their clinical trial data.
  • Datavant provides us with a broad array of built-in connections to real-world data sources, which can now be combined to yield a more holistic view of patient health than clinical trial data alone.
  • By linking real-world data sources with other sources of study data, clinical trial teams will be better equipped to generate and submit real-world evidence for regulatory assessment.

Trialbee Partners with Datavant to Power Patient-Centric Clinical Trial Recruitment and Engagement

Tuesday, June 23, 2020 - 1:00pm

Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Datavant, the leader in privacy-protecting data connectivity, to more effectively and efficiently recruit clinical trial participants.

Key Points: 
  • Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, today announced a partnership with Datavant, the leader in privacy-protecting data connectivity, to more effectively and efficiently recruit clinical trial participants.
  • This unique collaboration will improve specificity and drive the right patients to clinical trials, improving efficiency and time to last patient enrolled.
  • Trialbee will use Datavants open data ecosystem to power its innovative clinical trial recruitment and patient engagement solutions, analyzing de-identified data to determine the characteristics of patients who may be eligible and motivated to participate in a clinical trial.
  • Trialbee is a world leading technology provider in patient matching and engagement, empowering patients to participate in clinical trials as a care option.

MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) Begins Patient Recruitment

Wednesday, June 17, 2020 - 4:00pm

MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.

Key Points: 
  • MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.
  • MOTIVATE is registered as a non-interventional study in the US ( NCT04023019 ) and as a low-interventional, pragmatic trial in Europe( EudraCT No.
  • Dr Sidonio commented that "It is very exciting that patient recruitment for MOTIVATE has begun.
  • We expect MOTIVATE to provide valuable insights from real-world experience of haemophilia A patients who develop inhibitors to FVIII".

MOTIVATE (MOdern Treatment of Inhibitor-positiVe pATiEnts with haemophilia A) Begins Patient Recruitment

Wednesday, June 17, 2020 - 4:00pm

MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.

Key Points: 
  • MOTIVATE is a multicentre, investigator-initiated study to capture different approaches to the management of patients with haemophilia A and inhibitors.
  • MOTIVATE is registered as a non-interventional study in the US ( NCT04023019 ) and as a low-interventional, pragmatic trial in Europe( EudraCT No.
  • Dr Sidonio commented that "It is very exciting that patient recruitment for MOTIVATE has begun.
  • We expect MOTIVATE to provide valuable insights from real-world experience of haemophilia A patients who develop inhibitors to FVIII".

Phlexglobal Providing Vital Support for COVID-19 Clinical Trials

Tuesday, June 2, 2020 - 7:00pm

To help meet these needs, Phlexglobal is providing specialized technology and services to fast track COVID-19 trials without compromising quality .

Key Points: 
  • To help meet these needs, Phlexglobal is providing specialized technology and services to fast track COVID-19 trials without compromising quality .
  • To date, fifteen different companies have turned to Phlexglobal for clinical or regulatory support for COVID-19 studies or submissions.
  • In the early stages of the pandemic, Phlexglobal began support for a top-20 Biotech Company engaged in a global COVID-19 clinical trial.
  • Companies engaged in drug development should contact Phlexglobal at phlexglobal.com/contact for immediate regulatory and clinical support.

COVID-19 Clinical Trials Overview Featuring 140 Companies

Friday, May 29, 2020 - 1:00pm

All major trials from 2010 to 2020 and planned trials are included in the report scope.

Key Points: 
  • All major trials from 2010 to 2020 and planned trials are included in the report scope.
  • The report includes a panorama of COVID-19 clinical trials across the globe.
  • Companies and universities focusing on COVID-19 clinical trials are analyzed along with their trial participation (trial title, trial phase and current status).
  • 1.1 COVID-19 Clinical Trials Overview, 2020
    1.2.4 Drugs under Study for COVID-19 Treatment, 2020
    6 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details

COVID-19 Clinical Trials Guide - Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 - ResearchAndMarkets.com

Wednesday, May 27, 2020 - 12:25pm

All major trials from 2010 to 2020 and planned trials are included in the report scope.

Key Points: 
  • All major trials from 2010 to 2020 and planned trials are included in the report scope.
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided.
  • Companies and universities focusing on COVID-19 clinical trials are analyzed along with their trial participation (trial title, trial phase and current status).
  • 1.1 COVID-19 Clinical Trials Overview, 2020
    1.2.4 Drugs under Study for COVID-19 Treatment, 2020
    6 Trial Snapshots - Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details

CISCRP Explores the Impact of COVID-19 on Clinical Research

Tuesday, May 26, 2020 - 2:05pm

In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.

Key Points: 
  • In light of this, CISCRP conducted a brief survey among the public and patients in April 2020 to assess the impact of the pandemic on clinical research perceptions and experiences.
  • Of those who have participated in clinical research, more than half (56%) are currently enrolled in a clinical trial for COVID-19.
  • Overall, awareness of clinical trials remains low as 58% had not heard of a COVID-19 clinical research study recently.
  • The Center for Information and Study on Clinical Research Participation (CISCRP) is an internationally recognized non-profit organization dedicated to educating and informing the public and patients about clinical research.

GeoMap Clinical Patient Recruitment Platform Now Guarantees Enrollment Numbers

Tuesday, April 28, 2020 - 7:00am

SAN FRANCISCO, CA, Apr 28, 2020 - (ACN Newswire) - GeoMap Clinical, the award-winning digital patient recruitment platform, today announced a Patient Enrollment Guarantee, ideal for sponsors wanting guaranteed patient enrollment numbers.

Key Points: 
  • SAN FRANCISCO, CA, Apr 28, 2020 - (ACN Newswire) - GeoMap Clinical, the award-winning digital patient recruitment platform, today announced a Patient Enrollment Guarantee, ideal for sponsors wanting guaranteed patient enrollment numbers.
  • The GeoMap Platform is now offering guaranteed monthly enrollment targets for sponsors wanting to remove the risk of missing timelines due to slow or stalled enrollment.
  • The GeoMap Platform finds, screens, and then sends patients direct to sites via encrypted email - and doesn't keep their information.
  • The GeoMap Platform recruits for clinical trials in North America, Latin America, Australia, New Zealand, China, South Korea, Singapore, Thailand, and the EU.

StudyKIK Announces Casey Orvin Joining the Patient Recruitment & Technology Organization as Senior Vice President of Pharmaceutical Relationships

Monday, May 11, 2020 - 10:00am

IRVINE, Calif., May 11, 2020 /PRNewswire-PRWeb/ --StudyKIK, a patient recruitment and clinical trial technology company announced Casey Orvin has joined the organization as it's Senior Vice President of Pharmaceutical Relationships.

Key Points: 
  • IRVINE, Calif., May 11, 2020 /PRNewswire-PRWeb/ --StudyKIK, a patient recruitment and clinical trial technology company announced Casey Orvin has joined the organization as it's Senior Vice President of Pharmaceutical Relationships.
  • "Joining StudyKIK is an opportunity to connect patients with studies while aligning site-facing experience, and I'm thrilled to join a great team.
  • StudyKIK continues to lead in patient recruitment innovations & technology which in turn has made them extremely successful in decreasing enrollment timelines."
  • StudyKIK is a patient recruitment and technology platform that was founded on patient communities on all major social media channels to increase awareness for clinical trials.